Financhill
Back

Exelixis 10K Form

Buy
89

EXEL
Exelixis

Last Price:
34.31
Seasonality Move:
12.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive EXEL News And Ratings

See the #1 stock for the next 7 days that we like better than EXEL

EXEL Financial Statistics

Sales & Book Value

Annual Sales: $1.83B
Cash Flow: $262.14M
Price / Cash Flow: 25.49
Annual Sales: $7.96
Price / Book: 4.3

Profitability

EPS (TTM): 1.56000
Net Income (TTM): $466.92M
Gross Margin: $1.76B
Return on Equity: 20.97%
Return on Assets: 16.15%

Exelixis Earnings Forecast

Key Exelixis Financial Ratios

  • The Gross Profit Margin over the past 25 years for EXEL is 96.04%.
  • The Selling, General & Administrative Expenses for EXEL have been equal to 29.65% of Gross Profit Margin.
  • The Research & Development expenses have been 57.05% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of EXEL is 11.35% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 16 years.

Exelixis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EXEL
CUSIP: 30161Q
Website: exelixis.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.93
Quick Ratio: 3.7

Price-to-Earnings

Trailing P/E Ratio: 52.75
Forward P/E Ratio: 17.47

EXEL Technical Analysis vs Fundamental Analysis

Buy
89
Exelixis (EXEL) is a Buy

Is Exelixis a Buy or a Sell?

  • Exelixis stock is rated a Buy
    The current Exelixis [EXEL] share price is $34.29. The Score for EXEL is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.